Basic Information
| ID | DRAMP21141 |
|---|
| Sequence | KWCRKWQWRGVKFIKCV |
|---|
| Length | 17 |
|---|
| Name | AMP126 (De novo synthesis) |
|---|
| Source | Synthetic construct |
|---|
| Activity | Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram- |
|---|
| Pathogen | [Ref.23893489] Gram-positive bacteria : Staphylococcus aureus(MBC=46.5 μg/ml, 20.65 μM), MRSA(MBC>100 μg/ml, 55 μM), Streptococcus agalactiae(MBC=2.81 μg/ml, 1.24 μM);##Gram-negative bacteria : Pseudomonas aeruginosa(MBC=0.40 μg/ml, 0.17 μM), Escherichia coli(MBC=2.22 μg/ml, 0.98 μM), Salmonella enteritidis(MBC=10.8 μg/ml, 4.80 μM), Stenotrophomonas maltophilia(MBC=16.6 μg/ml, 7.37 μM) |
|---|
| Hemolytic Activity | [Ref.23893489] <1% hemolysis at 1 μg/ml , <1% hemolysis at 12.5 μg/ml , 5.30% hemolysis at 100 μg/ml , 6.9% hemolysis at 250 μg/ml , 12.5% hemolysis at 500 μg/ml against sheep red blood cells |
|---|
| Cytotoxicity | [Ref.23893489] The cytotoxicity (vs control) of P126 is 5% against HUVEC (endothelial) cells at a peptide concentration of 100 μg/ml. ##The cytotoxicity (vs control) of P126 is 6% agaisnt WI-38 (fibroblast) cells at a peptide concentration of 100 μg/ml. |
|---|
| N-terminal Modification | Free |
|---|
| C-terminal Modification | Free |
|---|
| Linear/Cyclic/Branched | Linear |
|---|
| Uniprot |
|
|---|
| PDB |
|
|---|
| 3D View | |
|---|
| PDB Download | Download PDB Predicted by Alphafold2 |
|---|
| PubMed ID | 23893489 |
|---|
